CCND2
Summary: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with CDK4 or CDK6 and functions as a regulatory subunit of the complex, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. Knockout studies of the homologous gene in mouse suggest the essential roles of this gene in ovarian granulosa and germ cell proliferation. High level expression of this gene was observed in ovarian and testicular tumors. Mutations in this gene are associated with megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3 (MPPH3). [provided by RefSeq, Sep 2014].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
cyclin D2 | MIM:123833 | Ensembl:ENSG00000118971 | HGNC:HGNC:1583 | PA26150 | 12p13.32 |
GO terms in CCND2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | IBA | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity |
BP | IBA | GO:0000278 | mitotic cell cycle |
BP | IDA | GO:0001934 | positive regulation of protein phosphorylation |
BP | IEA | GO:0007049 | cell cycle |
BP | IBA | GO:0007088 | regulation of mitotic nuclear division |
BP | IEA | GO:0007616 | long-term memory |
BP | IBA | GO:0008284 | positive regulation of cell proliferation |
BP | IMP | GO:0008284 | positive regulation of cell proliferation |
BP | IEA | GO:0008344 | adult locomotory behavior |
BP | IMP | GO:0043066 | negative regulation of apoptotic process |
BP | IDA | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
BP | IBA | GO:0045787 | positive regulation of cell cycle |
BP | IEA | GO:0051301 | cell division |
BP | IEA | GO:0071481 | cellular response to X-ray |
BP | IBA | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle |
BP | IMP | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle |
CC | IBA | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex |
CC | IDA | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex |
CC | IDA | GO:0000785 | chromatin |
CC | IBA | GO:0005634 | nucleus |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005730 | nucleolus |
CC | IBA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005829 | cytosol |
CC | IDA | GO:0031965 | nuclear membrane |
CC | IEA | GO:0097129 | cyclin D2-CDK4 complex |
MF | IBA | GO:0004672 | protein kinase activity |
MF | IPI | GO:0005515 | protein binding |
MF | IBA | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity |
MF | IBA | GO:0019901 | protein kinase binding |
MF | IPI | GO:0019901 | protein kinase binding |
Gene expression in normal tissue: CCND2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in CCND2
Database | Pathway ID | Pathway Des. |
---|---|---|
biocarta | cellcyclepathway | cyclins and cell cycle regulation |
biocarta | il2rbpathway | il-2 receptor beta chain in t cell activation |
biocarta | pitx2pathway | multi-step regulation of transcription by pitx2 |
reactome | R-HSA-1640170 | Cell Cycle |
reactome | R-HSA-212436 | Generic Transcription Pathway |
reactome | R-HSA-453279 | Mitotic G1-G1/S phases |
reactome | R-HSA-69231 | Cyclin D associated events in G1 |
reactome | R-HSA-69236 | G1 Phase |
reactome | R-HSA-69278 | Cell Cycle, Mitotic |
reactome | R-HSA-73857 | RNA Polymerase II Transcription |
reactome | R-HSA-74160 | Gene expression (Transcription) |
reactome | R-HSA-8878171 | Transcriptional regulation by RUNX1 |
reactome | R-HSA-8934593 | Regulation of RUNX1 Expression and Activity |
wikipathways | WP1530 | miRNA Regulation of DNA Damage Response |
wikipathways | WP179 | Cell Cycle |
wikipathways | WP1991 | SRF and miRs in Smooth Muscle Differentiation and Proliferation |
wikipathways | WP2261 | Signaling Pathways in Glioblastoma |
wikipathways | WP306 | Focal Adhesion |
wikipathways | WP34 | Ovarian Infertility Genes |
wikipathways | WP399 | Wnt Signaling Pathway and Pluripotency |
wikipathways | WP4172 | PI3K-Akt Signaling Pathway |
wikipathways | WP4249 | Hedgehog Signaling Pathway |
wikipathways | WP428 | Wnt Signaling Pathway |
wikipathways | WP45 | G1 to S cell cycle control |
wikipathways | WP49 | IL-2 Signaling Pathway |
wikipathways | WP707 | DNA Damage Response |
wikipathways | WP710 | DNA Damage Response (only ATM dependent) |
pid | betacatenin_nuc_pathway | Regulation of nuclear beta catenin signaling and target gene transcription |
pid | il2_stat5pathway | IL2 signaling events mediated by STAT5 |
pid | myc_activpathway | Validated targets of C-MYC transcriptional activation |
pid | rb_1pathway | Regulation of retinoblastoma protein |
kegg | hsa04068 | FoxO signaling pathway - Homo sapiens (human) |
kegg | hsa04110 | Cell cycle - Homo sapiens (human) |
kegg | hsa04115 | p53 signaling pathway - Homo sapiens (human) |
kegg | hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
kegg | hsa04218 | Cellular senescence - Homo sapiens (human) |
kegg | hsa04310 | Wnt signaling pathway - Homo sapiens (human) |
kegg | hsa04340 | Hedgehog signaling pathway - Homo sapiens (human) |
kegg | hsa04390 | Hippo signaling pathway - Homo sapiens (human) |
kegg | hsa04510 | Focal adhesion - Homo sapiens (human) |
kegg | hsa04630 | Jak-STAT signaling pathway - Homo sapiens (human) |
kegg | hsa04917 | Prolactin signaling pathway - Homo sapiens (human) |
kegg | hsa05162 | Measles - Homo sapiens (human) |
kegg | hsa05165 | Human papillomavirus infection - Homo sapiens (human) |
kegg | hsa05166 | HTLV-I infection - Homo sapiens (human) |
kegg | hsa05200 | Pathways in cancer - Homo sapiens (human) |
kegg | hsa05202 | Transcriptional misregulation in cancer - Homo sapiens (human) |
kegg | hsa05203 | Viral carcinogenesis - Homo sapiens (human) |
kegg | hsa05206 | MicroRNAs in cancer - Homo sapiens (human) |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD292 | NSC87877 | 1 |
iGMDRD85 | Ursolic acid | 2 |
iGMDRD351 | GW843682X | 1 |
iGMDRD237 | ABT-751 | 1 |
iGMDRD945 | ML214 | 3 |
iGMDRD84 | Lovastatin acid | 4 |
iGMDRD48 | Dexamethasone | 2 |
iGMDRD330 | BRD4132 | 1 |
iGMDRD307 | Manumycin A | 5 |
iGMDRD584 | VER 155008 | 3 |
iGMDRD248 | BRD4354 | 2 |
iGMDRD560 | MK-2206 | 4 |
iGMDRD286 | Nsc 632839 | 3 |
iGMDRD367 | Ro 28-1675 | 1 |
iGMDRD882 | CIL41 | 5 |
iGMDRD329 | Merck60 | 4 |
iGMDRD662 | JQ-1 | 1 |
iGMDRD209 | BRD6340 | 3 |
iGMDRD246 | NPC26 | 3 |
iGMDRD82 | Quiflapon | 2 |
iGMDRD158 | NSC141540 | 1 |
iGMDRD202 | Curcumin | 3 |
iGMDRD220 | fumonisin B1 | 2 |
iGMDRD289 | Parthenolide | 3 |
iGMDRD105 | Triptolide | 1 |
iGMDRD6 | AM-580 | 1 |
iGMDRD434 | BMS-536924 | 2 |
iGMDRD481 | Dactolisib | 1 |
iGMDRD267 | Oligomycin A | 1 |
iGMDRD231 | Importazole | 1 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD193 | Fqi1 | 1 |
iGMDRD280 | CYTOCHALASIN B | 1 |
iGMDRD126 | Tipifarnib | 2 |
iGMDRD210 | AC55649 | 3 |
iGMDRD554 | CHEMBL1434137 | 1 |
iGMDRD387 | CHIR-99021 | 1 |
iGMDRD599 | Salermide | 2 |
iGMDRD889 | Compound 7d-cis | 6 |
iGMDRD654 | SL 0101-1 | 1 |
iGMDRD425 | ERASTIN | 1 |
iGMDRD427 | ABT737 | 2 |
iGMDRD494 | Neopeltolide | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD188 | Piperlongumine | 4 |
iGMDRD577 | BIX01294 | 1 |
iGMDRD888 | Compound 44 | 2 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD183 | CDK4/6 inhibitor | 2 |
iGMDRD268 | Cerulenin | 2 |
iGMDRD23 | Gossypol | 2 |
iGMDRD524 | ISX-9 | 6 |
iGMDRD255 | SB225002 | 6 |
iGMDRD284 | Palbociclib | 1 |
iGMDRD478 | ABT-888 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in CCND2